- $15.14bn
- $20.86bn
- $6.91bn
- 64
- 77
- 31
- 58
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 4,416 | 3,059 | 3,065 | 7,498 | 6,909 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,569 | 3,962 | 4,435 | 4,920 | 4,595 |
Operating Profit | -1,152 | -903 | -1,371 | 2,578 | 2,314 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,597 | -1,254 | -1,570 | 2,335 | 2,103 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,222 | -959 | -1,142 | 1,781 | 1,735 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,222 | -959 | -1,143 | 1,771 | 1,735 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,222 | -959 | -1,143 | 1,771 | 1,735 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.133 | -2.44 | -2.79 | 5.42 | 4.58 |
Dividends per Share |